These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17371435)

  • 1. Molecular markers of circulating melanoma cells.
    Medic S; Pearce RL; Heenan PJ; Ziman M
    Pigment Cell Res; 2007 Apr; 20(2):80-91. PubMed ID: 17371435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients.
    Koyanagi K; Kuo C; Nakagawa T; Mori T; Ueno H; Lorico AR; Wang HJ; Hseuh E; O'Day SJ; Hoon DS
    Clin Chem; 2005 Jun; 51(6):981-8. PubMed ID: 15817820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
    Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
    Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.
    Hoon DS; Wang Y; Dale PS; Conrad AJ; Schmid P; Garrison D; Kuo C; Foshag LJ; Nizze AJ; Morton DL
    J Clin Oncol; 1995 Aug; 13(8):2109-16. PubMed ID: 7636555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.
    Taback B; Morton DL; O'Day SJ; Nguyen DH; Nakayama T; Hoon DS
    Recent Results Cancer Res; 2001; 158():78-92. PubMed ID: 11092035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma.
    Mocellin S; Del Fiore P; Guarnieri L; Scalerta R; Foletto M; Chiarion V; Pilati P; Nitti D; Lise M; Rossi CR
    Int J Cancer; 2004 Sep; 111(5):741-5. PubMed ID: 15252844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients.
    Huang SK; Hoon DS
    Mol Oncol; 2016 Mar; 10(3):450-63. PubMed ID: 26778792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell and circulating markers in melanoma: diagnosis, prognosis, and management.
    Kounalakis N; Goydos JS
    Curr Oncol Rep; 2005 Sep; 7(5):377-82. PubMed ID: 16091200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.
    Ireland A; Millward M; Pearce R; Lee M; Ziman M
    Clin Exp Metastasis; 2011 Apr; 28(4):327-36. PubMed ID: 21311956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method.
    Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance.
    Nezos A; Lembessis P; Sourla A; Pissimissis N; Gogas H; Koutsilieris M
    Clin Chem Lab Med; 2009; 47(1):1-11. PubMed ID: 19055471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute quantitative PCR for detection of molecular biomarkers in melanoma patients: a preliminary report.
    Vendittelli F; Paolillo C; Autilio C; Lavieri MM; Silveri SL; Capizzi R; Capoluongo E
    Clin Chim Acta; 2015 Apr; 444():242-9. PubMed ID: 25727516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in melanoma histopathology and diagnosis.
    Piris A; Mihm MC
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):467-80, viii. PubMed ID: 19464597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in molecular staging of melanoma patients: multimarker analysis of archival lymph node tissue.
    Busam KJ
    J Clin Oncol; 2003 Oct; 21(19):3550-1. PubMed ID: 12913105
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients.
    Kiyohara E; Hata K; Lam S; Hoon DS
    Methods Mol Biol; 2014; 1102():513-22. PubMed ID: 24258996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Biomarkers in Cutaneous Melanoma.
    Eisenstein A; Gonzalez EC; Raghunathan R; Xu X; Wu M; McLean EO; McGee J; Ryu B; Alani RM
    Mol Diagn Ther; 2018 Apr; 22(2):203-218. PubMed ID: 29411301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells.
    Berger TG; Haendle I; Schrama D; Lüftl M; Bauer N; Pedersen LØ; Schuler-Thurner B; Hohenberger W; Straten Pt Pt; Schuler G; Becker JC
    Int J Cancer; 2004 Aug; 111(2):229-37. PubMed ID: 15197776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current developments concerning malignant skin melanoma].
    Dargent M
    Maroc Med; 1972 Oct; 52(561):571-86. PubMed ID: 4667467
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
    Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
    Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.